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Six VanB phenotype-vanA genotype isolates of Enterococcus faecium with heterogeneous expression of teico-
planin resistance which gave rise to an outbreak at a Korean tertiary care teaching hospital have IS1216V in
the coding region of vanS. This could be the underlying cause of the VanB phenotype-vanA genotype with
heterogeneous expression of teicoplanin resistance.
VanA glycopeptide resistance is characterized by acquired
inducible resistance to both vancomycin and teicoplanin,
whereas the VanB phenotype is characterized by variable lev-
els of resistance to vancomycin but susceptibility to teicoplanin
(1, 5). During the past 5 years, vancomycin-resistant entero-
cocci (VRE) with the vanA genotype that are susceptible to
teicoplanin, hence having the VanB phenotype and the vanA
genotype, have become increasingly prevalent in Asia (8, 11,
12). In 2005, we experienced an outbreak of VanB phenotype-
vanA genotype Enterococcus faecium strains with heteroge-
neous expression of teicoplanin resistance isolated from six
patients at a tertiary care teaching hospital. To our knowledge,
this is the first description of IS1216V inserted in the coding
region of the vanS gene that might be involved in the hetero-
geneous expression of teicoplanin susceptibility.
From November to December 2005, six VanB phenotype-
vanA genotype E. faecium isolates (AJJ2, AJJ3, AJJ4, AJJ5,
AJJ8, and AJJ10) were collected from a tertiary care teaching
hospital. The organisms were identified by using conventional
biochemical reactions and a Vitek identification system (bio-
Me´rieux, Hazelwood, MO). To evaluate the genetic related-
ness of the isolates, pulsed-field gel electrophoresis (PFGE)
was performed with SmaI-digested genomic DNA (Gibco
BRL, Gaithersburg, MD) as described by Murray et al. (13),
with pulse times beginning with 1 s and ending with 20 s at 6
V/cm for 24 h. Dendrograms based on Dice coefficients and
clustered using an unweighted-pair group method using an
arithmetic averages algorithm were generated with Bio-Gene
software (Vilber Lourmat, Marne-la-Valle´e, France). All six
VanB phenotype-vanA genotype E. faecium isolates revealed
identical or closely related PFGE patterns according to the
method of Tenover et al. (14). The MICs of vancomycin and
teicoplanin for the isolates were determined by Etest (AB
Biodisk North America, Inc., Culver City, CA). Previously
characterized VRE strains, E. faecium BM4147 (3) and VanB
phenotype-vanA genotype E. faecium JC03 (12) without het-
erogeneous expression of teicoplanin resistance, served as con-
trols.
All isolates displayed various levels of vancomycin resistance
(MICs, 64 to 128 g/ml) and teicoplanin susceptibility (MICs,
4 to 12 g/ml) with heterogeneous expression of teicoplanin
resistance. The heterogeneous expression of resistance was
characterized by the growth of colonies in the elliptic inhibition
zone during Etest susceptibility testing (Fig. 1A). Colonies in
the elliptic inhibition zone displayed a homogeneous pheno-
type of resistance to teicoplanin when retested by Etest (Fig.
1B). VanB phenotype-vanA genotype E. faecium JC03 (12)
without heterogeneous expression of teicoplanin resistance
presented teicoplanin susceptibility and displayed no growth of
colonies in the inhibition zone (Fig. 1C), and E. faecium
BM4147 (3) displayed a homogeneous resistance to teicopla-
nin (Fig. 1D).
Bacterial DNA was extracted with a Qiagen DNeasy kit
(Qiagen GmbH, Hilden, Germany) according to the manufac-
turer’s instructions. For structural analysis of Tn1546-like ele-
ments, an overlapping PCR amplification of internal regions of
Tn1546 was performed as described previously (9). PCR am-
plicons larger than that of the prototype vanA gene cluster
were purified with Geneclean kits (Qbiogene, Inc., Carlsbad,
CA). The purified PCR products were sequenced directly by
using an ABI Prism 3100 DNA sequencer (Applied Biosys-
tems, Foster City, CA). DNA fragments amplified with a com-
bination of Tn1546 primer and IS1216V primer were also pu-
rified and subsequently sequenced to determine the exact
integration site and orientation of the IS1216V insertion.
DNASIS for Windows, version 2.6 (Hitachi Software Engi-
neering, South San Francisco, CA), was used for sequence
analysis. Nucleotide sequences were compared to the refer-
ence sequence of transposon Tn1546 (GenBank accession
number M97287) (3).
Filter matings were performed with Enterococcus faecalis
JH2-2 (10) as the recipient and all six isolates as the donors, as
previously described (15). Transconjugants were selected on
brain heart infusion (BHI) agar plates containing 50 g/ml of
rifampin, 20 g/ml of fusidic acid, and 10 g/ml of vancomycin.
The transconjugants were examined for the structural analysis
of Tn1546.
The induction of resistance to teicoplanin in VanB pheno-
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type-vanA genotype E. faecium AJJ5 with heterogeneous ex-
pression was studied by the determination of growth rates after
overnight incubation with or without teicoplanin. The isolate
was grown overnight at 37°C in BHI broth with or without
teicoplanin (6 g/ml). The cultures were diluted 1:20 into 20
ml of BHI with or without teicoplanin (6 g/ml), grown at 37°C
with shaking, and monitored for their optical density at 600
nm. Previously characterized VRE strains, E. faecium BM4147
(3) and VanB phenotype-vanA genotype E. faecium JC03 (12)
without heterogeneous expression of teicoplanin resistance,
served as controls.
A total of 12 isolates (six original isolates and six resistant
derivatives obtained from the elliptic inhibition zone on an
Etest strip, respectively) were characterized by one copy of
IS1216V in the left end of Tn1546, a second in the coding
region of vanS, and a third in the vanX-vanY intergenic region,
as well as IS1542 in the orf2-vanR intergenic region. IS1216V in
vanS was integrated at nucleotide 4900 with an 8-bp duplica-
tion of the target sequence (GTCATTAG) in the forward
orientation. Although the VanS sensor peptide was reported
earlier to have no functional effect due to the disruption of
vanS by IS1216V (6), IS1216V in the coding region of vanS in
our cases might affect the expression of teicoplanin resistance.
The VanRSA system activates transcription of the resistance
genes in response to vancomycin and teicoplanin, whereas
VanB-type enterococci remain susceptible to teicoplanin,
which is not an inducer (2, 7). Amino acid substitutions due to
the three point mutations of vanS are responsible for impaired
teicoplanin resistance among vanA genotype VRE strains (8).
On the other hand, the modification of signal transduction due
to substitutions in the putative linker of VanSB has been shown
to be the most common mechanism of acquisition of inducible
resistance to teicoplanin among vanB genotype VRE strains
(4). Similarly, the genetic alteration of vanS due to the IS1216V
insertion in our isolates might be associated with heteroge-
neous teicoplanin resistance.
All isolates transferred vancomycin resistance, at frequen-
cies of 6  109 to 2  108 transconjugants per donor. The
transconjugants revealed the same heterogeneous resistance to
teicoplanin.
In the growth rate studies, after overnight incubation of
AJJ5 with teicoplanin, growth was delayed at the beginning of
the subculture in the presence of teicoplanin, with growth
resuming after a lag phase of 4 h (Fig. 2A). The growth of
VanB phenotype-vanA genotype E. faecium JC03 without het-
erogeneous expression of teicoplanin resistance was sup-
pressed throughout the subculture in the presence of teicopla-
nin, regardless of prior overnight incubation (Fig. 2B). The
growth of BM4147 did not show any lag phase throughout the
subcultures either in the absence or presence of teicoplanin,
regardless of prior overnight incubation (Fig. 2C). The re-
sumption of growth of AJJ5, which is characterized by an
IS1216V insertion in the coding region of the vanS gene, in the
presence of teicoplanin after overnight incubation with teico-
planin and the homogeneous expression of teicoplanin resis-
tance in a colony within the inhibition zone suggest that a
portion of bacteria that retained teicoplanin resistance were
fully induced after incubation with teicoplanin.
The heterogeneous teicoplanin resistance of our isolates was
clinically important because the conventional test cannot de-
tect heterogeneous teicoplanin resistance. These isolates might
potentially give rise to homogeneous resistance during teico-
planin therapy. The results of PFGE showed genetically iden-
tical or closely related patterns for all isolates, indicating clonal
distribution (14). When VanB phenotype-vanA genotype E.
faecium strains are found, molecular typing and MIC determi-
FIG. 1. Teicoplanin (TP) MIC determination by Etest of E. faecium AJJ5 with heterogeneous expression of teicoplanin resistance (A), a colony
of E. faecium isolate AJJ5 grown in the inhibition zone next to the Etest strip (B), VanB phenotype-vanA genotype E. faecium JC03 without
heterogeneous expression of teicoplanin resistance (C), and E. faecium BM4147 (D).
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nation by Etest are recommended during teicoplanin therapy
to prevent a nosocomial outbreak.
This research was supported by a grant (06042KFDA126) from the
Korea Food and Drug Administration in 2006.
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FIG. 2. Effect of overnight growth in the presence of teicoplanin (6
g/ml; TP6) on E. faecium AJJ5 with heterogeneous expression of
teicoplanin resistance (A), VanB phenotype-vanA genotype E. faecium
JC03 without heterogeneous expression of teicoplanin resistance (B),
and E. faecium BM4147 (C) in the absence (0) or presence of teico-
planin. Teicoplanin concentration in the overnight culture/in the sub-
culture medium. O.D., optical density.
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